Weight maintenance: challenges, tools and strategies for primary care physicians
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Summary: Obesity is recognized as a chronic disease and one of the major healthcare challenges facing us today. Weight loss can be achieved via lifestyle, pharmacological and surgical interventions, but weight maintenance remains a lifetime challenge for individuals with obesity. Guidelines for the management of obesity have highlighted the role of primary care providers (PCPs). This review examines the long‐term outcomes of clinical trials to identify effective weight maintenance strategies that can be utilized by PCPs. Because of the broad nature of the topic, a structured PubMed search was conducted to identify relevant research articles, peer‐reviewed reviews, guidelines and articles published by regulatory bodies. Trials have demonstrated the benefit of sustained weight loss in managing obesity and its comorbidities. Maintaining 5–10% weight loss for ≥1 year is known to ameliorate many comorbidities. Weight maintenance with lifestyle modification – although challenging – is possible but requires long‐term support to reinforce diet, physical activity and behavioural changes. The addition of pharmacotherapy to lifestyle interventions promotes greater and more sustained weight loss. Clinical evidence and recently approved pharmacotherapy has given PCPs improved strategies to support their patients with maintenance of weight loss. Further studies are needed to assess the translation of these strategies into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 4×
“Half of the lifestyle intervention group achieved the 7% weight reduction goal after 24 weeks (63).”
BackgroundMethodInfluentialLifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Guh, D. P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C. L., & Anis, A. H. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-88 · Cited by 3,855
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020 · cited 4×
“Participants were randomized into three groups as follows: (i) the lifestyle intervention group received intensive training in diet, physical activity and behaviour modification (24-week curriculum), with the aim of losing ≥7% of their body weight and maintaining that weight loss; (ii) a second group received 850 mg o…”
BackgroundMethodInfluentialJensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735 · cited 7×
“Box 4 Models to guide primary care providers in managing obesity Relatively BMI-centric: AHA/ACC/TOS (12,13) • Evaluate and stage patients, decide who needs treat- ment based upon BMI, and explain the possible health benefits • Begin with comprehensive lifestyle intervention to achieve 5–10% weight loss • Consider med…”
BackgroundInfluentialA Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724
DONNELLY, J. E., BLAIR, S. N., JAKICIC, J. M., MANORE, M. M., RANKIN, J. W., & SMITH, B. K. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181949333 · Cited by 2,658
Global prevalence and trends of overweight and obesity among preschool children
de Onis, M., Blössner, M., & Borghi, E. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29786 · Cited by 2,182 · cited 1×
“4 billion adults are overweight (4), and both overweight and obesity are increasing in children (7).”
BackgroundChanges in Energy Expenditure Resulting from Altered Body Weight
Leibel, R. L., Rosenbaum, M., & Hirsch, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321001 · Cited by 2,012 · cited 1×
“leptin, cholecystokinin, glucagon-like peptide-1 [GLP1], amylin and peptide YY), which make you feel satiated, with the net result that appetite is increased (83,86,87).”
BackgroundLong-term weight loss maintenance
Wing, R. R., & Phelan, S. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.1.222s · Cited by 1,941 · cited 3×
“The initial weight-loss goal is 5–10% – a reduction that is sufficient to improve health and prevent or ameliorate many weight-related complications (18,24,25).”
BackgroundXENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915 · cited 2×
“Indeed, longer-term data (over 2 years) are available for several approved agents (97,104,117) and further studies are ongoing (118,119).”
BackgroundSjöström, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12012 · Cited by 1,835
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522 · cited 5×
“At 1 year, the ILI group, compared with the DSE group, had lost a greater percentage of their initial weight (−8.6% vs. −0.7%); had improved fitness (assessed by treadmill test); had improvements in HbA1c, systolic and diastolic blood pressure, triglyceride, highdensity lipoprotein (HDL)-cholesterol and urine albumin/…”
BackgroundMethodInfluentialLong-term persistence of hormonal adaptations to weight loss
Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105816 · Cited by 1,449
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402
Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.334 · Cited by 1,162 · cited 2×
“ILI participants had goals of 1,200–1,800 kcal d−1, based upon initial weight, and physical activity of >175 min week−1 (60).”
Background2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.003 · Cited by 1,160
Nauck, M., Frid, A., Hermansen, K., Shah, N. S., Tankova, T., Mitha, I. H., Zdravkovic, M., Düring, M., Matthews, D. R., & for the LEAD-2 Study Group (2009) · Diabetes Care · doi:10.2337/dc08-1355 · Cited by 1,129
Avenell, A., Broom, J., Brown, T., Poobalan, A., Aucott, L., Stearns, S., Smith, W., Jung, R., Campbell, M., & Grant, A. (2004) · Health Technology Assessment · doi:10.3310/hta8210 · Cited by 1,041 · cited 2×
“type 2 diabetes and improved glucose control in patients with type 2 diabetes (38).”
BackgroundOrchard, T. J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S., Fowler, S., & for the Diabetes Prevention Program Research Group (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-8-200504190-00009 · Cited by 948 · cited 1×
“Compared with placebo, lifestyle intervention and treatment with metformin had reduced the incidence of type 2 diabetes by, respectively, 58% and 31% (63), and had reduced the incidence of metabolic syndrome by 41% and 17% (64).”
BackgroundKlein, S., Burke, L. E., Bray, G. A., Blair, S., Allison, D. B., Pi-Sunyer, X., Hong, Y., & Eckel, R. H. (2004) · Circulation · doi:10.1161/01.cir.0000145546.97738.1e · Cited by 934 · cited 1×
“Serum triglycerides and low-density lipoproteincholesterol levels typically decrease with weight loss, but return to former levels after weight regain (38,50,51).”
BackgroundMulticenter, placebo-controlled trial of lorcaserin for weight management.
Smith, S. R., Weissman, N. J., Anderson, C. M., Sanchez, M., Chuang, E., Stubbe, S., Bays, H., & Shanahan, W. R. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909809 · Cited by 911 · cited 1×
“Indeed, longer-term data (over 2 years) are available for several approved agents (97,104,117) and further studies are ongoing (118,119).”
BackgroundEight-year weight losses with an intensive lifestyle intervention: The look AHEAD study
The Look AHEAD Research Group (2014) · Obesity · doi:10.1002/oby.20662 · Cited by 842
on behalf of the NN8022-1923 Investigators, Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V, Hale, P. M., & Aronne, L. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.120 · Cited by 842
Svetkey, L. P. (2008) · JAMA · doi:10.1001/jama.299.10.1139 · Cited by 748
Allison, D. B., Gadde, K. M., Garvey, W. T., Peterson, C. A., Schwiers, M. L., Najarian, T., Tam, P. Y., Troupin, B., & Day, W. W. (2012) · Obesity · doi:10.1038/oby.2011.330 · Cited by 711
Self-citationLi, G., Zhang, P., Wang, J., An, Y., Gong, Q., Gregg, E. W., Yang, W., Zhang, B., Shuai, Y., Hong, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70057-9 · Cited by 684
Health benefits of gastric bypass surgery after 6 years
Adams, T. D., Davidson, L. E., Litwin, S. E., Kolotkin, R. L., LaMonte, M. J., Pendleton, R. C., Strong, M. B., Vinik, R., Wanner, N. A., Hopkins, P. N., et al. (2012) · JAMA · doi:10.1001/2012.jama.11164 · Cited by 674
Wadden, T. A., Foreyt, J. P., Foster, G. D., Hill, J. O., Klein, S., O'Neil, P. M., Perri, M. G., Pi‐Sunyer, F. X., Rock, C. L., Erickson, J. S., et al. (2011) · Obesity · doi:10.1038/oby.2010.147 · Cited by 558
Weight management using a meal replacement strategy: meta and pooling analysis from six studies.
Heymsfield, S. B., van Mierlo, C. A. J., van der Knaap, H. C. M., Heo, M., & Frier, H. I. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802258 · Cited by 557
Foster, G. D. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.266 · Cited by 538 · cited 1×
“Such benefits include improvements in cardiometabolic disease (cardiovascular disease risk, diabetes, dyslipidaemia, hypertension, metabolic syndrome, non-alcoholic fatty liver disease and prediabetes) (12,26), depression (27), gastroesophageal reflux disease (28), osteoarthritis (9), polycystic ovary syndrome (29), s…”
BackgroundAchieving Weight and Activity Goals Among Diabetes Prevention Program Lifestyle Participants
The Diabetes Prevention Program Research Group (2004) · Obesity Research · doi:10.1038/oby.2004.179 · Cited by 529
Four-year weight losses in the Look AHEAD study: factors associated with long-term success
Wadden, T. A., Neiberg, R. H., Wing, R. R., Clark, J. M., Delahanty, L. M., Hill, J. O., Krakoff, J., Otto, A., Ryan, D. H., Vitolins, M. Z., et al. (2011) · Obesity · doi:10.1038/oby.2011.230 · Cited by 465
Effects of Dietary Composition on Energy Expenditure During Weight-Loss Maintenance
Ebbeling, C. B., Swain, J. F., Feldman, H. A., Wong, W. W., Hachey, D. L., Garcia-Lago, E., & Ludwig, D. S. (2012) · JAMA · doi:10.1001/jama.2012.6607 · Cited by 431
Weight-loss maintenance for 10 years in the National Weight Control Registry
Thomas, J. G., Bond, D. S., Phelan, S., Hill, J. O., & Wing, R. R. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.08.019 · Cited by 358 · cited 6×
“If individuals do not self-monitor and revert to disinhibited or unhealthy eating habits, they will not be able to overcome these regulatory changes, and weight regain occurs (52).”
BackgroundInfluentialScreening for Obesity in Adults: Recommendations and Rationale
U.S. Preventive Services Task Force* (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00012 · Cited by 347
The defence of body weight: a physiological basis for weight regain after weight loss
Sumithran, P., & Proietto, J. (2013) · Clinical Science · doi:10.1042/cs20120223 · Cited by 310
Trends in weight regain following roux-en-Y gastric bypass (RYGB) bariatric surgery
Cooper, T. C., Simmons, E. B., Webb, K., Burns, J. L., & Kushner, R. F. (2015) · Obesity Surgery · doi:10.1007/s11695-014-1560-z · Cited by 305 · cited 1×
“Furthermore, over one-third of patients experienced excessive weight regain (≥25% of lost weight) (128).”
BackgroundOrlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1108 · Cited by 287
Purnell, J. Q., Zinman, B., & Brunzell, J. D. (2013) · Circulation · doi:10.1161/circulationaha.111.077487 · Cited by 267
Aucott, L., Poobalan, A., Smith, W. C. S., Avenell, A., Jung, R., & Broom, J. (2005) · Hypertension · doi:10.1161/01.hyp.0000165680.59733.d4 · Cited by 241
Garvey, W. T., Garber, A. J., Mechanick, J. I., Bray, G. A., Dagogo-Jack, S., Einhorn, D., Grunberger, G., Handelsman, Y., Hennekens, C. H., Hurley, D. L., et al. (2014) · Endocrine Practice · doi:10.4158/ep14280.ps · Cited by 238 · cited 1×
“Patients with overweight and obesity require secondary prevention and treatment, or tertiary interventions if there are associated weight-related complications (3), as is the case with other diseases such as type 2 diabetes and hypertension.”
BackgroundSelf-citationAppetite after weight loss by energy restriction and a low-fat diet–exercise follow-up
Doucet, E., Imbeault, P., St-Pierre, S., Alméras, N., Mauriège, P., Richard, D., & Tremblay, A. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801251 · Cited by 236
Kuna, S. T., Reboussin, D. M., Borradaile, K. E., Sanders, M. H., Millman, R. P., Zammit, G., Newman, A. B., Wadden, T. A., Jakicic, J. M., Wing, R. R., et al. (2013) · Sleep · doi:10.5665/sleep.2618 · Cited by 231 · cited 1×
“For example, if patients with diabetes, hypertension or sleep apnoea are able to sustain lower glycosylated haemoglobin A1c (HbA1c) (44), lower blood pressure (33), and alleviate apnoea (10) over the period of weight loss, this can lower the health risks these diseases exert on patients over their lifetime.”
BackgroundDelahanty, L. M., Pan, Q., Jablonski, K. A., Aroda, V. R., Watson, K. E., Bray, G. A., Kahn, S. E., Florez, J. C., Perreault, L., Franks, P. W., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0018 · Cited by 125 · cited 2×
“Furthermore, the early rapid weight loss (and its subsequent maintenance for 2 years) had also provided the additional benefit of a reduction in the risk of developing type 2 diabetes (65).”
BackgroundLong-Term Weight Loss From Lifestyle Intervention Benefits Blood Pressure?: A Systematic Review
Aucott, L., Rothnie, H., McIntyre, L., Thapa, M., Waweru, C., & Gray, D. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.135178 · Cited by 124 · cited 2×
“Sustained weight loss (3 kg lost over 2–3 years) leads to reductions in blood pressure (32,33).”
BackgroundRetention rates and weight loss in a commercial weight loss program
Finley, C. E., Barlow, C. E., Greenway, F. L., Rock, C. L., Rolls, B. J., & Blair, S. N. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803395 · Cited by 117
Impact of weight regain on metabolic disease risk: a review of human trials.
Kroeger, C. M., Hoddy, K. K., & Varady, K. A. (2014) · Journal of Obesity · doi:10.1155/2014/614519 · Cited by 55
Cited by
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
The Effects of Exercise and Physical Activity on Weight Loss and Maintenance
Swift, D. L., McGee, J. E., Earnest, C. P., Carlisle, E., Nygard, M., & Johannsen, N. M. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.07.014 · Cited by 536
Long-term weight loss maintenance for obesity: a multidisciplinary approach
Marchesini, G., Montesi, L., El Ghoch, M., Brodosi, L., Calugi, S., & Dalle Grave, R. (2016) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s89836 · Cited by 320
Exercise in the management of obesity
Petridou, A., Siopi, A., & Mougios, V. (2019) · Metabolism · doi:10.1016/j.metabol.2018.10.009 · Cited by 317
Obesity and cardiovascular health
Welsh, A., Hammad, M., Piña, I. L., & Kulinski, J. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae025 · Cited by 239
Metadata
- Authors
- Soleymani, T., Daniel, S., & Garvey, W. T.
- Venue
- Obesity Reviews
- Publisher
- Wiley
- Published
- 2015-10-21
- Volume
- 17
- Issue
- 1
- Pages
- 81-93
- ISSN
- 1467-7881 (ISSN-L)
- 1467-789X
- OpenAlex
- W2149496929
- Cited by
- 91
- References
- 50
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.